| NCT03406416 |
Study of a Suprachoroidal Retinal Prosthesis |
https://ClinicalTrials.gov/show/NCT03406416 |
Active, not recruiting |
Mobius Medical Pty Ltd. |
2020-12-31 |
| NCT04355689 |
Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome |
https://ClinicalTrials.gov/show/NCT04355689 |
Recruiting |
Nacuity Pharmaceuticals, Inc. |
2023-06-30 |
| NCT03381235 |
Exercise and RP (AVAMC and Emory) |
https://ClinicalTrials.gov/show/NCT03381235 |
Completed |
Emory University |
2018-11-28 |
| NCT03374657 |
A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT03374657 |
Recruiting |
Novartis |
2026-07-28 |
| NCT03368027 |
Effectiveness of a Cognitive-behavioral Program of Coping With Psychological Stress in People With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT03368027 |
Completed |
Universidad de Granada |
2018-12-03 |
| NCT03328130 |
Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B Gene |
https://ClinicalTrials.gov/show/NCT03328130 |
Recruiting |
Horama S.A. |
2022-09-30 |
| NCT03252847 |
Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) Retinitis Pigmentosa GTPase Regulator (RPGR) |
https://ClinicalTrials.gov/show/NCT03252847 |
Active, not recruiting |
MeiraGTx UK II Ltd |
2020-11-30 |
| NCT03248388 |
Argus II/ORCAM Device Study |
https://ClinicalTrials.gov/show/NCT03248388 |
Recruiting |
Mayo Clinic |
2021-12-31 |
| NCT03116113 |
A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT03116113 |
Recruiting |
NightstaRx Ltd, a Biogen Company |
2021-03-31 |
| NCT03078309 |
The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients |
https://ClinicalTrials.gov/show/NCT03078309 |
Recruiting |
Hadassah Medical Organization |
2020-08-31 |
| NCT03073733 |
Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT03073733 |
Active, not recruiting |
jCyte, Inc |
2020-09-30 |
| NCT03063021 |
The FIGHT-RP1 Study |
https://ClinicalTrials.gov/show/NCT03063021 |
Completed |
Johns Hopkins University |
2019-02-11 |
| NCT03057496 |
Collision Warning Device for Blind and Visually Impaired |
https://ClinicalTrials.gov/show/NCT03057496 |
Completed |
Massachusetts Eye and Ear Infirmary |
2019-11-08 |
| NCT02909985 |
Visual Activity Evoked by Infrared in Humans After Dark Adaptation |
https://ClinicalTrials.gov/show/NCT02909985 |
Completed |
University of New Mexico |
2016-08-31 |
| NCT02837640 |
Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02837640 |
Recruiting |
Beirut Eye Specialist Hospital |
2017-06-30 |
| NCT02720640 |
Safety and Efficacy of the Alpha AMS Subretinal Implant |
https://ClinicalTrials.gov/show/NCT02720640 |
Completed |
University of Oxford |
2017-10-31 |
| NCT02709876 |
Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02709876 |
Active, not recruiting |
Stem Cells Arabia |
2020-09-30 |
| NCT02670980 |
Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy |
https://ClinicalTrials.gov/show/NCT02670980 |
Completed |
Pixium Vision SA |
2019-05-31 |
| NCT02614651 |
AUgmented REality for the Visually Impaired - Part 1 |
https://ClinicalTrials.gov/show/NCT02614651 |
Completed |
Centre Hospitalier Universitaire de Nīmes |
2017-04-20 |
| NCT02609165 |
Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema |
https://ClinicalTrials.gov/show/NCT02609165 |
Completed |
Ospedale San Raffaele |
2017-02-28 |
| NCT03011541 |
Stem Cell Ophthalmology Treatment Study II |
https://ClinicalTrials.gov/show/NCT03011541 |
Recruiting |
MD Stem Cells |
2022-01-31 |
| NCT03845218 |
Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome Measures |
https://ClinicalTrials.gov/show/NCT03845218 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-03-30 |
| NCT02556736 |
RST-001 Phase I/II Trial for Advanced Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02556736 |
Active, not recruiting |
Allergan |
2020-12-03 |
| NCT02464436 |
Safety and Tolerability of hRPC in Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02464436 |
Recruiting |
ReNeuron Limited |
2020-01-31 |
| NCT02320812 |
Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02320812 |
Completed |
jCyte, Inc |
2017-07-19 |
| NCT02280135 |
Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02280135 |
Completed |
Red de Terapia Celular |
2017-03-31 |
| NCT02244996 |
Cone Rescue in Retinitis Pigmentosa by the Treatment of Lycium Barbarum |
https://ClinicalTrials.gov/show/NCT02244996 |
Completed |
The Hong Kong Polytechnic University |
2016-04-30 |
| NCT02140164 |
Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02140164 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-11-30 |
| NCT02110225 |
A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP) |
https://ClinicalTrials.gov/show/NCT02110225 |
Completed |
Dompé Farmaceutici S.p.A |
2015-11-30 |
| NCT02086890 |
Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02086890 |
Active, not recruiting |
Nova Southeastern University |
2020-06-30 |
| NCT03326336 |
Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT03326336 |
Recruiting |
GenSight Biologics |
2021-12-31 |
| NCT01864486 |
Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy |
https://ClinicalTrials.gov/show/NCT01864486 |
Completed |
Pixium Vision SA |
2017-10-13 |
| NCT01847365 |
TES for the Treatment of RP |
https://ClinicalTrials.gov/show/NCT01847365 |
Completed |
University of Oxford |
2015-02-28 |
| NCT01837901 |
Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01837901 |
Completed |
Okuvision GmbH |
2013-08-31 |
| NCT01835002 |
Transcorneal Electrical Stimulation - Multicenter Safety Study |
https://ClinicalTrials.gov/show/NCT01835002 |
Completed |
Okuvision GmbH |
2014-07-31 |
| NCT01736059 |
Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy |
https://ClinicalTrials.gov/show/NCT01736059 |
Enrolling by invitation |
University of California, Davis |
2022-01-31 |
| NCT01680510 |
The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil |
https://ClinicalTrials.gov/show/NCT01680510 |
Recruiting |
Sheba Medical Center |
2020-12-31 |
| NCT01604356 |
Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01604356 |
Completed |
Johns Hopkins University |
2013-12-31 |
| NCT01603576 |
Pilot Study of a Suprachoroidal Retinal Prosthesis |
https://ClinicalTrials.gov/show/NCT01603576 |
Completed |
Center for Eye Research Australia |
2014-08-31 |
| NCT01560715 |
Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01560715 |
Completed |
University of Sao Paulo |
2013-01-31 |
| NCT01543906 |
Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65) |
https://ClinicalTrials.gov/show/NCT01543906 |
Completed |
QLT Inc. |
2014-07-31 |
| NCT01531348 |
Feasibility and Safety of Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01531348 |
Enrolling by invitation |
Mahidol University |
2020-12-31 |
| NCT01530659 |
Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01530659 |
Active, not recruiting |
Neurotech Pharmaceuticals |
2019-08-31 |
| NCT01521793 |
Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01) |
https://ClinicalTrials.gov/show/NCT01521793 |
Completed |
QLT Inc. |
2014-05-31 |
| NCT01497379 |
Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients |
https://ClinicalTrials.gov/show/NCT01497379 |
Completed |
Retina Implant AG |
2014-01-31 |
| NCT01399515 |
Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01399515 |
Completed |
Seoul National University Hospital |
2013-08-31 |
| NCT02617966 |
Rod and Cone Mediated Function in Retinal Disease |
https://ClinicalTrials.gov/show/NCT02617966 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2024-12-30 |
| NCT04419285 |
Mobility Protocol Adapted for Advanced Visually Impaired Subjects |
https://ClinicalTrials.gov/show/NCT04419285 |
Recruiting |
Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts |
2024-06-02 |
| NCT04356716 |
Sildenafil for Treatment of Choroidal Ischemia |
https://ClinicalTrials.gov/show/NCT04356716 |
Recruiting |
Columbia University |
2021-04-30 |
| NCT04319809 |
Object Finder for a Retinal Prosthesis |
https://ClinicalTrials.gov/show/NCT04319809 |
Active, not recruiting |
Minnesota HealthSolutions |
2021-04-30 |
| NCT04315025 |
Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT04315025 |
Completed |
PT. Prodia Stem Cell Indonesia |
2019-06-20 |
| NCT04295304 |
NR600 System Retinal Prosthesis for Patients With Retinal Degenerative Diseases |
https://ClinicalTrials.gov/show/NCT04295304 |
Recruiting |
Nano Retina |
2021-12-30 |
| NCT04285398 |
Prospective Natural History Study of Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT04285398 |
Recruiting |
SparingVision |
2021-06-01 |
| NCT04284293 |
CNS10-NPC for the Treatment of RP |
https://ClinicalTrials.gov/show/NCT04284293 |
Recruiting |
Cedars-Sinai Medical Center |
2022-04-30 |
| NCT04278131 |
BS01 in Patients With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT04278131 |
Recruiting |
Bionic Sight LLC |
2022-06-30 |
| NCT04252534 |
Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma |
https://ClinicalTrials.gov/show/NCT04252534 |
Completed |
Ankara Universitesi Teknokent |
2019-12-30 |
| NCT04238858 |
Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT04238858 |
Completed |
Ankara Universitesi Teknokent |
2017-02-28 |
| NCT04141891 |
Advancing Understanding of Transportation Options |
https://ClinicalTrials.gov/show/NCT04141891 |
Recruiting |
University of Colorado, Denver |
2023-08-01 |
| NCT04129021 |
Multimodal Ophthalmic Imaging |
https://ClinicalTrials.gov/show/NCT04129021 |
Recruiting |
Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts |
2023-06-30 |
| NCT04123626 |
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene |
https://ClinicalTrials.gov/show/NCT04123626 |
Recruiting |
ProQR Therapeutics |
2021-10-07 |
| NCT04120883 |
Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO) |
https://ClinicalTrials.gov/show/NCT04120883 |
Recruiting |
University of Michigan |
2022-10-31 |
| NCT04068207 |
Minocycline Treatment in Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT04068207 |
Recruiting |
Sun Yat-sen University |
2021-12-01 |
| NCT04008771 |
Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases |
https://ClinicalTrials.gov/show/NCT04008771 |
Completed |
2C Tech Corp |
2014-12-19 |
| NCT03999021 |
FIGHT-RP 1 Extension Study |
https://ClinicalTrials.gov/show/NCT03999021 |
Active, not recruiting |
Johns Hopkins University |
2021-06-30 |
| NCT03780257 |
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene |
https://ClinicalTrials.gov/show/NCT03780257 |
Recruiting |
ProQR Therapeutics |
2021-12-31 |
| NCT03772938 |
Stem Cells Therapy in Degenerative Diseases of the Retina |
https://ClinicalTrials.gov/show/NCT03772938 |
Enrolling by invitation |
Pomeranian Medical University Szczecin |
2020-02-28 |
| NCT03635645 |
Experimental and Clinical Studies of Retinal Stimulation |
https://ClinicalTrials.gov/show/NCT03635645 |
Recruiting |
University of Michigan |
2020-10-31 |
| NCT03444961 |
CAREN Argus Rehab (CARE) Study |
https://ClinicalTrials.gov/show/NCT03444961 |
Completed |
The Cleveland Clinic |
2018-06-20 |
| NCT01256697 |
The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01256697 |
Completed |
Sheba Medical Center |
2009-04-30 |
| NCT01235624 |
Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / Genes |
https://ClinicalTrials.gov/show/NCT01235624 |
Completed |
University Hospital, Montpellier |
2013-04-30 |
| NCT01233609 |
Trial of Oral Valproic Acid for Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01233609 |
Completed |
Foundation Fighting Blindness |
2015-12-31 |
| NCT01068561 |
Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01068561 |
Completed |
University of Sao Paulo |
2010-01-31 |
| NCT01024803 |
Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients |
https://ClinicalTrials.gov/show/NCT01024803 |
Completed |
Retina Implant AG |
2017-04-30 |
| NCT01014052 |
Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations |
https://ClinicalTrials.gov/show/NCT01014052 |
Completed |
QLT Inc. |
2012-08-31 |
| NCT04234438 |
Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser |
https://ClinicalTrials.gov/show/NCT04234438 |
Completed |
Ankara Universitesi Teknokent |
2019-10-30 |
| NCT03963154 |
Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation |
https://ClinicalTrials.gov/show/NCT03963154 |
Recruiting |
Centre d’Etude des Cellules Souches |
2021-12-15 |
| NCT03944239 |
Safety and Efficacy of Subretinal Transplantation of Clinical Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT03944239 |
Recruiting |
Chinese Academy of Sciences |
2021-10-31 |
| NCT04448860 |
Validation of Standardized Test Protocols to Assess the Impact of Visual Pathologies in Daily Life Activities |
https://ClinicalTrials.gov/show/NCT04448860 |
Recruiting |
Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts |
2023-10-04 |
| NCT00804102 |
Transcorneal Electrical Stimulation Therapy for Retinal Disease |
https://ClinicalTrials.gov/show/NCT00804102 |
Completed |
Okuvision GmbH |
2011-04-30 |
| NCT03316560 |
Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations |
https://ClinicalTrials.gov/show/NCT03316560 |
Recruiting |
Applied Genetic Technologies Corp |
2023-03-31 |
| NCT04224207 |
Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton’s Jelly Derived Mesenchymal Stem Cells |
https://ClinicalTrials.gov/show/NCT04224207 |
Completed |
Ankara Universitesi Teknokent |
2019-10-30 |
| NCT00717080 |
The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction |
https://ClinicalTrials.gov/show/NCT00717080 |
Completed |
Aurolab |
2010-05-31 |
| NCT00661479 |
An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00661479 |
Completed |
Allergan |
2009-12-31 |
| NCT00515814 |
Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptors |
https://ClinicalTrials.gov/show/NCT00515814 |
Completed |
Retina Implant AG |
2009-12-31 |
| NCT00461435 |
Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00461435 |
Completed |
Azienda Policlinico Umberto I |
NA |
| NCT00447993 |
A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00447993 |
Completed |
Neurotech Pharmaceuticals |
2009-10-31 |
| NCT00447980 |
A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00447980 |
Completed |
Neurotech Pharmaceuticals |
2010-07-31 |
| NCT00346333 |
Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A |
https://ClinicalTrials.gov/show/NCT00346333 |
Completed |
National Eye Institute (NEI) |
2008-12-31 |
| NCT00345917 |
Safety Study in Retinal Transplantation for Retinitis Pigmentosa. |
https://ClinicalTrials.gov/show/NCT00345917 |
Completed |
Radtke, Norman D., M.D. |
2012-03-31 |
| NCT00279500 |
Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00279500 |
Completed |
Second Sight Medical Products |
2014-12-31 |
| NCT00100230 |
DHA and X-Linked Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00100230 |
Completed |
Retina Foundation of the Southwest |
2012-05-31 |
| NCT00065455 |
Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00065455 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00063765 |
Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye |
https://ClinicalTrials.gov/show/NCT00063765 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00029289 |
Effects of Lutein in Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00029289 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |
| NCT00004827 |
Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00004827 |
Completed |
FDA Office of Orphan Products Development |
NA |
| NCT00000116 |
Randomized Trial for Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00000116 |
Completed |
National Eye Institute (NEI) |
NA |
| NCT00000114 |
Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00000114 |
Completed |
National Eye Institute (NEI) |
NA |